Which hedge funds own CNTA? CENTESSA PHARMACEUTICALS PLC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in CNTA (CENTESSA PHARMACEUTICALS PLC) in their Q2 2026 13F filings, worth $0 in total. 67 exited: EcoR1 Capital, LLC, 5AM Venture Management, LLC, First Light Asset Management, LLC.
- 0
- Holders
- 0
- New this quarter
- 67
- Exited this quarter
- $0
- Combined value
- 0.0%
- Share of managers holding
Holders, Q2 2026
Exited since the previous filing
Ownership over time
By quarter
| Quarter | Holders | Managers filing | Share holding | Combined value |
|---|---|---|---|---|
| Q2 2026 | 0 | 1,205 | 0.0% | $0 |
| Q1 2026coverage widened | 67 | 1,209 | 5.5% | $3.1bn |
| Q4 2025 | 6 | 71 | 8.5% | $203m |
| Q3 2025 | 5 | 73 | 6.8% | $139m |
| Q2 2025 | 5 | 73 | 6.8% | $105m |
| Q1 2025 | 7 | 73 | 9.6% | $145m |
| Q4 2024 | 5 | 74 | 6.8% | $148m |
| Q3 2024 | 6 | 73 | 8.2% | $135m |
| Q2 2024 | 4 | 73 | 5.5% | $36.6m |
| Q1 2024 | 3 | 73 | 4.1% | $32.2m |
| Q4 2023 | 3 | 73 | 4.1% | $17.2m |
| Q3 2023 | 3 | 73 | 4.1% | $13.6m |
| Q2 2023 | 3 | 73 | 4.1% | $16.9m |
| Q1 2023 | 3 | 73 | 4.1% | $9.7m |
| Q4 2022 | 2 | 73 | 2.7% | $927k |
| Q3 2022 | 2 | 74 | 2.7% | $1.2m |
| Q2 2022 | 2 | 74 | 2.7% | $7.1m |
| Q1 2022 | 3 | 74 | 4.1% | $48.1m |
| Q4 2021 | 3 | 74 | 4.1% | $61.7m |
| Q3 2021 | 3 | 71 | 4.2% | $79.5m |
| Q2 2021 | 4 | 71 | 5.6% | $49.9m |
Who discovered CNTA first?
Earliest meaningful positions among the 11 tracked managers seen opening CNTA since Q2 2021.
| Avidity Partners Management LP | Q3 2024 | 1.7% | Exited by Q2 2025 | −10% |
| Farallon Capital Management, L.L.C. | Q1 2024 | 0.03% | Exited by Q2 2026 | +76% |
Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.
60 already held it when coverage began
5AM Venture Management, LLC (Q1 2026), Adage Capital Partners GP, L.L.C. (Q1 2026), ADAR1 Capital Management, LLC (Q1 2026), Affinity Asset Advisors, LLC (Q1 2026), Alpine Associates Management Inc. (Q1 2026), Alyeska Investment Group, L.P. (Q1 2026), AQR Arbitrage LLC (Q1 2026), Aquatic Capital Management LLC (Q1 2026), Atom Investors LP (Q1 2026), Avoro Capital Advisors LLC (Q1 2026), Baker Bros. Advisors LP (Q1 2026), Balyasny Asset Management L.P. (Q1 2026), Bayforest Capital Ltd (Q1 2026), Boothbay Fund Management, LLC (Q1 2026), Braidwell LP (Q1 2026), Burkehill Global Management, LP (Q1 2026), Candriam S.C.A. (Q1 2026), Caption Management, LLC (Q1 2026), Cinctive Capital Management LP (Q1 2026), Citadel Advisors LLC (Q1 2026), Cormorant Asset Management, LP (Q1 2026), D. E. Shaw & Co., Inc. (Q1 2026), Deep Track Capital, LP (Q1 2026), Eagle Health Investments LP (Q1 2026), EcoR1 Capital, LLC (Q1 2026), First Light Asset Management, LLC (Q1 2026), Fortress Investment Group LLC (Q1 2026), Fox Run Management, L.L.C. (Q1 2026), Freestone Grove Partners LP (Q1 2026), GABELLI & Co INVESTMENT ADVISERS, INC. (Q1 2026), Glazer Capital, LLC (Q1 2026), Greenland Capital Management LP (Q1 2026), HighVista Strategies LLC (Q1 2026), Ikarian Capital, LLC (Q1 2026), Jain Global LLC (Q1 2026), Logos Global Management LP (Q1 2026), Marshall Wace, LLP (Q1 2026), Millennium Management LLC (Q1 2026), Nantahala Capital Management, LLC (Q1 2026), Octagon Capital Advisors LP (Q1 2026), Paradigm Biocapital Advisors LP (Q1 2026), Perceptive Advisors LLC (Q1 2026), PFM Health Sciences, LP (Q1 2026), Qube Research & Technologies Ltd (Q1 2026), Rangeley Capital, LLC (Q1 2026), Rock Springs Capital Management LP (Q1 2026), RTW Investments, LP (Q1 2026), Schonfeld Strategic Advisors LLC (Q1 2026), Silverarc Capital Management, LLC (Q1 2026), Spruce Street Capital LP (Q1 2026), Squarepoint Ops LLC (Q1 2026), SummitTX Capital, L.P. (Q1 2026), TIG Advisors, LLC (Q1 2026), Trexquant Investment LP (Q1 2026), Two Sigma Investments, LP (Q1 2026), Voleon Capital Management LP (Q1 2026), Voloridge Investment Management, LLC (Q1 2026), Weiss Asset Management LP (Q1 2026), Y-Intercept (Hong Kong) Ltd (Q1 2026), Yakira Capital Management, Inc. (Q1 2026)